Study of ALTO-101 in Patients With Schizophrenia

Clinical trial NCT06502964 · RECRUITING

Trial details

NCT number: NCT06502964
Sponsor: Alto Neuroscience
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Cognitive Impairment

Start date: 2024-06-11
Primary completion: 2026-02-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.